期刊文献+

胃癌相关miRNA表达的表观遗传学调控机制 被引量:10

Epigenetic Regulation of microRNA Gene Expression in Gastric Carcinoma
原文传递
导出
摘要 胃癌是人类最常见的肿瘤之一,其发病机制尚不完全清楚.微小RNA(microRNA,miRNA)是一组最近发现的长度为22个核苷酸左右的非编码RNA,具有负性调控基因表达的功能.本文对miRNA在胃癌发生中的作用及其表达调控机制进行综述.不断有文献显示,miRNA在多种肿瘤(包括胃癌)的发生过程中发挥着重要作用.作者和其他研究人员发现,miRNA的表达异常(如:miR-421和miR-21的上调或/和miR-31和miR-218的下调等)与胃癌的发生相关,提示miRNA是胃癌发生的重要因素.目前,miRNA表达的分子机制尚未完全明了.最近研究较清楚地显示,miRNA的表达受到DNA甲基化和组蛋白修饰等机制的调控.这说明,胃癌相关miRNA的表达水平受到表观遗传机制的调控。 Gastric cancer is one of the most common cancers in human.The tumorigenesis of this type of cancer is poorly understood.Recently,microRNAs(miRNAs) have been identified as a group of non-coding RNAs having ~ 22 nucleotides to downregulate gene expression.In this review,the role of miRNAs in the development of gastric cancer and the mechanisms of their expression were summarized.Increasing evidence from literatures has indicated that miRNA play an important role in the development of various cancers,including gastric cancer.We and others have demonstrated the association of gastric cancer with the abnormality of miRNA expression,such as up-regulation of miR-421 and miR-21 and /or down-regulation of miR-31 and miR-218,suggesting that these miRNAs are oncogenic factors for gastric cancer.To date,the molecular mechanisms of miRNA expression have not been well studied,but recent studies have clearly shown that miRNA expression is regulated by DNA methylation and histone modification,indicating that the levels of miRNAs in gastric cancer may be controlled by the epigenetic mechanisms.
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2010年第12期1090-1096,共7页 Chinese Journal of Biochemistry and Molecular Biology
基金 国家自然科学基金(No.30872420) 浙江省自然科学基金(No.Y207240,No.Y207244) 浙江省公益性技术应用研究计划(No.2010C33112) 宁波市自然科学基金(No.2009A610134、No.2010A610044)~~
关键词 胃癌 微小RNA 表观遗传学 基因表达调控 gastric cancer miRNA epigenetics regulation of gene expression
  • 相关文献

参考文献6

二级参考文献103

  • 1杨少辉,戴冬秋.甲基化特异性PCR技术的分析及改良[J].肿瘤研究与临床,2006,18(9):594-595. 被引量:7
  • 2关志宇,戴冬秋,孟春风.5-aza-2’-deoxycitydine诱导胃癌细胞系TIMP3基因去甲基化和转录上调的实验性探讨[J].中国肿瘤临床,2006,33(23):1334-1337. 被引量:2
  • 3朱新江,戴冬秋.表遗传学与胃肠道肿瘤[J].世界华人消化杂志,2006,14(34):3251-3256. 被引量:16
  • 4Egger G,Hzng G,Aparicio A,et al.Epigmetics in human disease and for epigenetic therapy. Nature, 2004,429(6990) : 457-463.
  • 5Klose RJ, Bird AP. Genomic DNA methylation:the mark and its mediators. Trends Biochem Sci,2006,31(2) :89-97.
  • 6Paers AH,Mermoud JE,O'Carroll D,et al,Histone H3 lysine 9 methylation is an epigenefie imprint of faeultative heteroehromatin. Nat Genet, 21302, 30 ( 1 ) :77-80.
  • 7Heard E, Rougeulle C, Arnand D, et al. Methylation of histane H3 at Lys-9 is an early mark on the X chromosome during X inactivation. Cell,2001, 107 ( 6 ) : 727-738.
  • 8Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and downregulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia.Proc Natl Acad Sci U S A,2002,99(24): 15524- 15529.
  • 9Cimmino A,Calin GA,Fabbri M,et al.miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A,2005,102(39):13944-13949.
  • 10Iorio MV,Ferracin M,Liu CG,et al.MicroRNA gene expression deregulation in human breast cancer. Cancer Res, 2005,65 ( 16 ) : 7065-7070.

共引文献106

同被引文献210

引证文献10

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部